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Introduction
During vertebrate embryogenesis, two sequential waves of hematopoiesis occur termed primitive and definitive. In zebrafish, primitive erythropoiesis initiates in the intermediate cell mass (ICM) in posterior lateral mesoderm, giving rise to erythrocytes and macrophages before 1 day post-fertilization (dpf), followed by definitive hematopoiesis when stem/progenitors are produced from hemogenic endothelium in the ventral wall of the dorsal aorta. At the time of primitive erythroid cell generation, lymphocytes and granulocytes arise from an anterior lateral mesoderm domain. After 2 dpf, a major niche for hematopoiesis is present in caudal hematopoietic tissue in the tail. Eventually, the kidney serves as the major site of hematopoiesis through adulthood in the zebrafish 1 
.
Gata1 is a key transcription factor that is essential for blood cell development. In addition to controlling cell survival and proliferation, Gata1 directly binds to and activates expression of erythroid-specific globin genes, the erythropoietin receptor and its own promoter [2] [3] [4] . Knockout of Gata1 in the mouse leads to embryonic lethality due to severe yolk sac anemia, consistent with a loss of primitive erythropoiesis 5 . A zebrafish gata1 mutant has normal expression levels for markers of hematopoietic stem/progenitor, myeloid, and lymphoid cells, but a complete loss of erythroid gene expression through 24 hours post fertilization (hpf) 6 . RNA binding proteins (RBPs) are recognized to play key regulatory roles in development, including hematopoiesis. Several RBPs bind AU-rich elements (AREs) in the 3'UTR, which are present in approximately 5-8% of mammalian transcripts 7 . Several
For personal use only. on September 14, 2017 . by guest www.bloodjournal.org From 4 distinct RBPs have been identified, including ARE-binding factor-1 (AUF1), embryonic lethal and abnormal vision (ELAV) family members, ZFP36 family members, and KHtype splicing regulatory protein (KHRP). AUF1 has 4 distinct isoforms (p37, p40, p42 and p45) and regulates many genes that are involved in hematopoiesis, for example Bcl2 and Il8 8, 9 . Knockout of all four AUF1 isoforms in mice leads to reduced numbers of splenic T and B cells, suggesting that AUF1 has an important role in lymphopoiesis 10 .
KSRP can also regulate many hematopoietic target genes, including Cxcl2, Cxcl3, Il6, Tlr4 11 . Recently, analysis of Zfp36L2 knockout mice showed the critical role of this RNA binding protein in self-renewal of erythroid progenitors 12 . These studies indicate that post-transcriptional gene regulatory mechanisms are important in hematopoiesis.
The ELAV family contains 4 members, the ubiquitously expressed Elavl1 (HuR, HuA), and neuronal Elavl2 (HuB), Elavl3 (HuC), and Elavl4 (HuD). Recently, Elavl4 was shown to be also expressed in pancreatic beta cells and to regulate the translation of insulin 13 . Elavl1 has been shown to play an essential role in embryonic development and stem/progenitor cell survival in adult mice 14, 15 . Hematopoietic and intestinal progenitors were significantly depleted in Elavl1 -/-conditionally-deleted mice due to a p53-dependent cell death program 14 . During embryonic development, Elavl1 -/-embryos appeared normal at day 8.5; however embryos could not survive beyond E14.5 15 . At E10.5 toE12.5, knockout embryos exhibited defects in placental development. We showed recently that knockdown of elavl1 during zebrafish embryogenesis generates defects in angiogenesis of the subintestinal vein plexus, consistent with its role in regulation of VEGF-A expression 16 . However, the function of elavl1 in embryonic
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From 5 hematopoietic development has not been characterized, in part due to the early embryonic lethality of the mouse knockout. Here we used the zebrafish model to evaluate functional roles of elavl1 during embryonic blood development. We report that elavl1 regulates gata1 expression at the post-transcriptional level and thereby promotes embryonic erythropoiesis.
Materials and Methods

Zebrafish maintenance
Wildtype and p53 -/-mutant zebrafish 17 were maintained at 28.5C. Embryos were collected from adult fish after natural matings and staged as described 18 . All animal studies were approved by the WCMC Animal Care and Use Committee.
Whole mount in situ hybridization
Whole mount in situ hybridization was performed using single-stranded RNA probes labeled with digoxigenin-uridine 5-triphosphate (Roche) essentially as described 19 . The gata1, lmo2, scl, myod, nkx2.5, and pax2a riboprobes were synthesized and hybridized as described 20 . Briefly, fixed and staged embryos were washed in PBST for 5 min and pre-hybridized for 3 hr, followed by hybridization with the indicated probe overnight.
After a series of stringent washes, embryos were blocked in 2% BSA, 1% FBS saline buffer, incubated with AP-conjugated antibody overnight, and stained with BCIP/NBT substrate (Roche).
For
Cell culture
The MEL, HEK293 and HEK293T cell lines were maintained in DMEM growth medium containing high glucose (4.5 g/L) (Sigma), L-glutamine, 10% fetal bovine serum and 1x antibiotics (Invitrogen). Cells were cultured at 37C in a humidified atmosphere containing 5% CO 2 .
RT-PCR and Quantitative real-time PCR
First-strand cDNA synthesis was performed using the Omniscript Synthesis System for RT-PCR (Qiagen). Primers (F: 5'-GAGTCTCTTCAGCAGCATTGG, R: 5'-CCTGATGCCTGATCAAC) were used for amplification of total elavl1a and elavl1b cDNA. For qPCR, the cDNA was mixed with SYBR Green Mix (Quanta) and product measured using an ABI 7500 real-time PCR machine (Applied Biosystems). Each sample was prepared in triplicate, and all experiments were repeated 3 times. The CT values were determined using the 2
Whole mount immunohistochemistry
Zebrafish embryos were fixed overnight in 4% PFA and processed for whole mount immunohistochemistry with anti-ELAVL1 antibody (Clonegene), and then incubated with HRP-conjugated secondary antibody (KPL). Bright field images were captured using a Zeiss Axioscope2 microscope with an AxioCam digital camera (Zeiss) or with a dissecting microscope (Olympus). 
Western blotting
Zebrafish embryos were deyolked or directly lysed in RIPA buffer on ice for at least 30 min. Protein concentrations of each sample were measured using a BCA Kit (Thermo Scientific). 15 μg of protein was electrophoresed in a 10% SDS PAGE gel. Protein was transferred to PVDF membranes (Millipore) and immuno-blotted with anti-human ELAVL1 monoclonal antibody (1:5000, Clonegene or Santa Cruz), anti-beta-Actin monoclonal antibody (1:5000, Sigma), or anti-human GATA1 polyclonal antibody (1:5000, Abcam) for at least 1 hr at RT or 4C overnight. HRP-conjugated goat antimouse or anti-rabbit secondary antibody (KPL) was added and signal developed in ECL solution (Millipore).
Immuno-precipitation
Cell lysates were pre-cleared with Sepharose beads (GE Healthcare) and incubated with anti-ELAVL1 antibody (Clonegene or Santa Cruz) conjugated agarose beads overnight. The beads were washed with 0.1% Triton X-100 in PBS twice, then boiled with sample loading buffer for western blotting. The binding of Elavl1 with gata1 mRNA was measured by immuno-precipitation followed by qPCR as described After 24 hr, 10-20 embryos were collected as one sample and luciferase activity was measured in lysates using a luminometer (Promega). Firefly Luciferase values were normalized with Renilla luciferase values and for each experiment n was at least 3 samples. At least three replicates were tested per experiment.
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Statistics
Data are expressed as means +/-S.E.M. Statistical significance was determined by twotailed unpaired Student's t-test or chi-squared test with Prism software. For the rescue experiment in Fig. 2 , the statistical analysis used each of the four criteria as a degree of freedom in chi-squared analysis. Thus, we did not require an embryo to be fully rescued along all four characteristics, and an embryo rescued for even one of the characteristics was scored as a rescue.
Results
Elavl1a regulates zebrafish embryonic development
ELAVL1 is highly conserved in vertebrates, and by protein-homology comparison in the ENSEMBL database, two zebrafish Elavl1 orthologs were clearly identified (Supplemental Fig. S1 ), encoded by genes we designated elavl1a and elavl1b.
Predicted protein sequence analysis showed that both orthologs are highly related, with Elavl1a and Elavl1b 85% and 82% similar to the human protein, respectively. Genomic We quantified the relative transcript levels derived from each of the two zebrafish elavl1 genes during embryogenesis, by designing a single pair of PCR primers that amplify cDNA derived from both genes. Restriction enzyme polymorphisms were then used to distinguish the relative contribution of each gene to the total cDNA pool 23 . Semiquantitative RT-PCR experiments demonstrated that elavl1a represents the major expressed isoform, constituting 80-90% of total elav1 transcripts throughout early embryogenesis, from the one cell stage until 120 hpf (Fig. 1A, B) . Given that elavl1a has a more conserved genomic structure and predominates for expression during embryonic development, we focused our functional studies on this gene. In situ hybridization experiments confirmed that elavl1a transcripts are deposited maternally and expressed widely during early stages of embryogenesis (Fig. 1C) .
When the zebrafish protein was expressed in HEK293 cells, monoclonal anti-ELAVL1 antibodies generated against the human protein specifically cross-reacted with the zebrafish Elavl1a protein, according to western blotting analysis (Fig. S3A) . Utilizing this antibody, whole mount immuno-staining was performed with zebrafish embryos, which confirmed that Elavl1 is expressed maternally and then ubiquitously through 120 hpf of development (Fig. 1D) . There was general concordance between RNA and protein expression patterns.
To determine whether elavl1a plays a role in zebrafish embryonic development, two morpholinos (MOs) were designed and validated to specifically target the elavl1a gene 1 1 including a translational blocking MO (Mo1) and a splice-blocking MO (Mo2), as indicated in Fig. S2A . Using the cross-reacting antibody, we confirmed the efficacy of both Mo1 and Mo2, finding that 7-8 ng effectively eliminates the targeted protein expression, while 3.5 ng reduces expression levels to around 40% of controls ( Fig. 2A-B ). Mo2 effectively blocked the generation of properly spliced RNA product (Fig. 2C) . To avoid potential off-targeting effects using higher concentrations, we used 4 ng MO for subsequent experiments, which reproducibly achieves a knockdown of greater than 50%. Our previous study 16 reported angiogenesis phenotypes at 72 hpf. Here we show that at 24 hpf, embryos injected with 4 ng elavl1 Mo1 (373/408 embryos, 91%) or Mo2
(130/134 embryos, 97%) showed a general developmental delay, curved tails, neural defects including small eyes, and pericardial edema; the fish failed to survive beyond 5 dpf ( Fig. 2D-E) . As a further test for whether these phenotypes were specifically induced by loss of elavl1, mRNA encoding mouse Elavl1, which does not contain the MO binding site (75 pg/embryo), was co-injected with 4 ng elavl1a Mo1, and this partially rescued defective development (Chi square, p<0.001, Fig. 2F ). The embryos were never rescued for all aspects of development, although this could be due to technical challenges in the rescue assay. These experiments indicate that elavl1a is essential for early zebrafish development.
Elavl1a regulates erythropoiesis
Visual inspection suggested that blood cells were markedly reduced or absent in the circulation of elavl1a morphants. We therefore evaluated hematopoiesis in these embryos. Indeed, the morphants had significantly decreased levels of globin transcripts
and hemoglobin as shown by in situ hybridization for hbbe3 at 24 or 48 hpf and oDianisidine staining for hemoglobin at 48 hpf (Fig. 3A-F) . The difference was more pronounced at 48 hpf in the morphant, indicating that the defect in erythropoiesis was not due simply to developmental delay. Morphants co-injected with elavl1a mRNA were also stained for globin transcripts and hemoglobin at 48 hpf, as shown by representative samples in Supplemental Fig. S4 . While few of the morpholino-injected embryos showed substantial staining, this was increased to 55% or 83% of the embryos (for hemoglobin or globin RNA, respectively) when elavl1a mRNA was co-injected. We used a gata1:dsRed transgenic line to purify erythroid cells by flow cytometry from batches of wildtype or morphant embryos, followed by cytospin to evaluate blood morphology.
Erythroid cells, which are far fewer in the morphant embryos, appear relatively large and immature compared to wildtype, as shown by representative images in Supplemental ELAVL1 can regulate p53 expression following UV irradiation by direct association with the p53 3'-UTR region, by regulating p-VHL, or indirectly by stabilizing Mdm2, a p53 protein E3 ligase 14, 24, 25 . Therefore, we tested whether the loss of hbbe3 signal was caused by p53-induced apoptosis. A similar loss in hbbe3 transcripts at 24 or 48 hpf, as well as the absence of o-Dianisidine staining at 48 hpf was found following elavl1a knockdown in p53 -/-mutant embryos, although brain degeneration and eye phenotypes were improved (Fig. 3G-L) . In addition to the erythroid deficit, the pericardial edema phenotype was not rescued in p53 -/-mutants. Thus, the erythropoiesis defect occurs 1 3 independently of p53, suggesting that elavl1a specifically regulates embryonic erythropoiesis during zebrafish development.
Elavl1a regulates gata1 expression
To investigate the molecular basis for the erythropoiesis defect following Elavl1a depletion, the expression of various hematopoietic regulatory genes was evaluated by in situ hybridization. At the 5-somite stage, expression of the stem/progenitor markers lmo2 and scl appear normal in control and elavl1a morphants (Fig. 4A-D) , whereas levels of the erythroid gata1 transcript are decreased ( Fig. 4E-F ). This loss of gata1 transcript levels was still evident at the 15-somite stage, while transcripts for lmo2 and scl are similar in control and elavl1a morphants (Fig. 4G-N) . Quantitative RT-PCR (qPCR) analysis confirmed the overall reduction in gata1 mRNA levels of elavl1 morphants at both 5-and 15-somite stages of development (Fig. 5A) . Therefore, gata1 mRNA levels are specifically decreased during stages of primitive erythropoiesis following depletion of elavl1a, while other hematopoietic regulatory genes including lmo2 and scl are relatively unaffected. We also examined the expression levels of Gata1 protein. Anti-human GATA1 polyclonal antibody recognized zebrafish Gata1 protein expressed in HEK293 cells (Supplemental Fig. S3A ). In elavl1a morphants, the Gata1 protein levels are reduced at both 5-and 15-somite stages, although less so than for the RNA, compared to control morphants (p<0.05, Fig. 5B-C be relatively stable up to these stages of development. These data indicate that elavl1 regulates the expression of gata1, an essential regulator of erythropoiesis during embryonic development.
Elavl1a function in mesoderm is relatively restricted
We next tested whether the phenotype described in elavl1a morphants is specific to blood cells, or represents a more general defect in mesoderm lineage differentiation.
For this purpose, whole mount in situ hybridization experiments evaluated transcript levels for myod (somitic mesoderm and muscle), ntl (axial mesoderm and notochord), pax2a (lateral mesoderm and pronephros), and nkx2.5 (anterior lateral mesoderm and cardiomyocytes). As shown in Fig. 6A -L, elavl1a morphant embryos exhibit similar transcript patterns compared to the control embryos at the 5-or 15-somite stages for myod, ntl, and pax2a. Interestingly, nkx2.5 (the cardiac mesoderm marker) is relatively decreased in the elavl1a morphants at the 15-somite stage (Fig. 6M-N) . The results suggest that knockdown of elavl1a does not cause a general defect in mesoderm development, but causes specific defects in expression of gata1 and nkx2.5, which could explain phenotypes in erythropoiesis (gata1) and perhaps contribute to pericardial edema (nkx2.5).
Elavl1a binds gata1 mRNA and promotes expression
Elavl1 is known to positively regulate gene expression by binding to ARE elements in the 3'UTR of target mRNAs 26 . Since gata1 transcripts were significantly depleted in elavl1a morphant embryos, we analyzed the zebrafish gata1 untranslated region and For personal use only. on September 14, 2017. by guest www.bloodjournal.org From 1 5 found 3 potential Elavl1 binding sites (Supplemental Fig. S6 ). We hypothesized that by binding to these sites Elav1a could stabilize gata1 transcript levels. Therefore, we tested whether Elavl1 can bind directly gata1 3' UTR sequences by performing immunoprecipitation assays. Using HEK293 cell lysates as a positive control, monoclonal antibodies were shown to precipitate both human and zebrafish versions of the Elavl1 protein (shown in Supplemental Fig. S3B) . Therefore, the interaction between Elavl1
protein and gata1 transcript was tested by RNA immuno-precipitation (RIP). When zebrafish Elavl1a and a transcript containing the gata1 3' UTR sequences were expressed in HEK293 cells, the Elavl1a-specific antibody showed a 20-fold increase in RNA pull-down compared to the controls using IgG or no antibody (Fig. 7A) , suggesting that Elavl1a binds directly to the 3'UTR of the gata1 mRNA. The efficiency of pull-down was substantially decreased when the expressed RNA contained site-specific mutations in the putative Elavl1a binding sites. These data indicate that Elavl1 binds to specific elements in the 3'UTR of the gata1 mRNA. Sequence analysis suggested that the mouse Gata1 3' UTR contains 2 predicted Elavl1 predicted binding sites, and sequence alignment suggests that in zebrafish and mouse Gata1 at least one of these 3'UTR elements are conserved (Supplemental Fig. S4 ). Therefore, we hypothesized that murine Gata1 RNA is also a direct target of mouse ELAVL1 and performed RIP assays using lysates from the mouse erythroleukemia (MEL) cell line. We found a 9-fold enhanced precipitation of Gata1 transcripts using anti-ELAVL1 antibody compared with controls using IgG or no antibody (Fig. 7B ).
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From 1 6 We next tested directly whether cis-elements that promote Elavl1a binding affect gata1 transcript function. For this purpose, widltype or mutated versions of the zebrafish gata1 3'UTR were fused downstream of a luciferase reporter gene and constructs were microinjected into developing embryos. Luciferase activity was quantified (normalized by activity of a control Renilla luciferase reporter in the same pmir-Glo vector) comparing control luciferase, the luciferase fused to wildtype gata1 3'-UTR, or the luciferase fused to the gata1 UTR with putative Elavl1 binding sites mutated. As shown in Fig. 7C , elavl1 MOs strongly suppress gata1 3'UTR-linked luciferase expression.
Similar low levels of luciferase were found when the elavl1-binding sites are mutated on the 3'UTR (and are not further affected by inclusion of the MO). These data suggest that the binding of Elavl1a on the gata1 3'UTR promotes the expression of this erythroidspecific transcription factor.
Elavl1a regulates gata1 expression and erythropoiesis in vivo
To confirm that Elavl1a regulates gata1 in erythroid progenitors, wildtype or mutated zebrafish gata1 3'-UTR sequences were fused downstream of the firefly luciferase reporter in transgenic constructs with the reporters placed under control of the erythroidspecific gata1 promoter, which restricts expression to the developing red cells in the embryonic ICM [27] [28] [29] . Constructs were injected into zebrafish embryos and reporter activity was quantified at 24 hpf. The transgenic embryos containing the wildtype gata1 3'UTR expressed significantly higher levels of luciferase activity compared with transgenic embryos harboring the mutant construct. Furthermore, this increased luciferase activity was suppressed by knock-down of elavl1a by a co-injected MO (Fig.   For personal 
7D
). To determine if gata1 is a critical gene targeted by elavl1 affecting erythropoiesis, gata1 mRNA was injected in elavl1a morphants. Indeed, 40% of the embryos showed a substantial increase in hemoglobin staining at 48 hpf compared to uninjected morphants, (Chi square, p<0.001), and a partial but significant rescue of embryonic globin RNA expression according to qPCR and in situ hybridization experiments (Fig.   7E-G) .
Discussion
Elavl1 is an RNA-binding protein that we find is well conserved between humans and zebrafish. Zebrafish Elavl1 is encoded by two genes, presumably duplicated and then retained in the fish genome. The predominant isoform expressed during embryogenesis is encoded by the elavl1a gene, with transcripts and protein found as maternal products and then widely throughout the developing embryo. We showed that knockdown of this gene has major effects on embryonic development, such that by 48 hpf the body axis is much shorter and neural tissues are degenerated. The embryos also develop with a striking deficit of embryonic blood cells. While defects in hematopoiesis may be caused indirectly through early embryonic morphogenetic alterations, our data suggest phenotypes that are caused by direct deregulation of gata1, a key regulator of the erythroid lineage. In contrast to markers for other mesodermal derivatives, gata1 transcript levels are decreased even as early as the 5-somite stage, and co-injection of gata1 RNA is able to at least partially restore erythropoiesis to the elavl1a morphant embryos. The results indicate that altered gata1 transcript levels caused by knockdown of Elavl1a protein are sufficient to deregulate embryonic erythropoiesis. At least some 1 8 activity for Elavl1 appears to function through binding sites present in the gata1 3'UTR.
We did not find a difference for rescue, comparing the gata1 mRNAs with wildtype or mutated 3'UTR, but this might reflect technical challenges of the rescue assay, since over-expression with injected RNA could over-ride the balance of regulatory mechanisms acting through the 3'UTR.
In summary, the major finding of this study is that the Elavl1 RNA-binding protein can bind and stabilize gata1 transcripts during embryonic erythropoiesis, as a posttranscriptional mechanism to enhance Gata1 expression and regulate red cell development. Embryos depleted of Elavl1a, which is the predominant isoform in zebrafish embryos, had specific defects in gata1 transcript levels, Gata1 protein levels, and primitive embryonic erythropoiesis. Elavl1 can bind to the gata1 3'-UTR, dependent on AU-rich sites that match the Elavl1 consensus binding sequence, and this feature appears to be conserved in the mouse gene. Our data show that post-transcriptional regulation of gata1, a key transcriptional regulatory factor for the erythroid lineage, provides a previously unrecognized post-transcriptional regulatory mechanism for embryonic erythropoiesis. 
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